Literature DB >> 7040016

Excretion of drugs in human breast milk.

R M Welch, J W Findlay.   

Abstract

The present report briefly discusses some of the morphological, physiological, and compositional aspects of animal and human breast milk and how these characteristics might be important for the accumulation of drugs and foreign compounds. In addition, a study is described confirming the presence of caffeine, codeine, morphine, phenacetin, acetaminophen, and salicylic acid in the breast milk of a lactating mother following oral administration of a combination analgesic containing aspirin, phenacetin, caffeine, and codeine. Although the study is limited to one subject, it has provided critically needed data on the rates of appearance in, and elimination of these drugs from, breast milk. A similar amount of information is presented on phenacetin, also a component of the analgesic mixture, which has not been previously reported to enter human milk. The distribution of these drugs between the slightly more acidic breast milk and the relatively neutral plasma is consistent with their weakly basic, acidic, or relatively neutral properties. In general, the study shows that codeine and morphine milk concentrations are higher than, salicylic acid milk levels are much lower than, and phenacetin, caffeine, and acetaminophen milk concentrations are relatively similar to their respective plasma levels. It is projected, from estimated steady-state milk concentrations of the drugs and their metabolites studied, that very low percentages of the therapeutic dosages (less than 0.7%) would be excreted in mother's milk, too low an amount to be clinically significant to the infant.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7040016     DOI: 10.3109/03602538108994032

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  7 in total

1.  The physiology of the normal human breast: an exploratory study.

Authors:  Dixie Mills; Eva J Gordon; Ashley Casano; Sarah Michelle Lahti; Tinh Nguyen; Alex Preston; Julie Tondre; Kuan Wu; Tiffany Yanase; Henry Chan; David Chia; Mahtash Esfandiari; Tiffany Himmel; Susan M Love
Journal:  J Physiol Biochem       Date:  2011-10-08       Impact factor: 4.158

Review 2.  Improving the risk assessment of lipophilic persistent environmental chemicals in breast milk.

Authors:  Geniece M Lehmann; Marc-André Verner; Bryan Luukinen; Cara Henning; Sue Anne Assimon; Judy S LaKind; Eva D McLanahan; Linda J Phillips; Matthew H Davis; Christina M Powers; Erin P Hines; Sami Haddad; Matthew P Longnecker; Michael T Poulsen; David G Farrer; Satori A Marchitti; Yu-Mei Tan; Jeffrey C Swartout; Sharon K Sagiv; Clement Welsh; Jerry L Campbell; Warren G Foster; Raymond S H Yang; Suzanne E Fenton; Rogelio Tornero-Velez; Bettina M Francis; John B Barnett; Hisham A El-Masri; Jane Ellen Simmons
Journal:  Crit Rev Toxicol       Date:  2014-08       Impact factor: 5.635

3.  Excretion of trazodone in breast milk.

Authors:  R K Verbeeck; S G Ross; E A McKenna
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

4.  Pharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers.

Authors:  Brioni R Moore; Sam Salman; John Benjamin; Madhu Page-Sharp; Gumal Yadi; Kevin T Batty; Peter M Siba; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2015-05-11       Impact factor: 5.191

Review 5.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

6.  Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers.

Authors:  J W Findlay; R F Butz; J M Sailstad; J T Warren; R M Welch
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

7.  The pharmacokinetics of tetrabenazine and its hydroxy metabolite in patients treated for involuntary movement disorders.

Authors:  M S Roberts; S McLean; K S Millingen; H M Galloway
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.